Literature DB >> 21075164

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).

Germaine Hanquet1, Pierre Van Damme, Daniel Brasseur, Xavier De Cuyper, Simon Gregor, Martin Holmberg, Rebecca Martin, Zsuzsanna Molnár, Maria Grazia Pompa, René Snacken, Marianne van der Sande, Marc Van Ranst, Angela Wirtz, Pieter Neels.   

Abstract

This European workshop identified a number of lessons learnt in the field of vaccine licensure, prioritization of target groups, communication on pandemic vaccines, implementation of vaccination and safety monitoring. The mild severity of the pandemic A(H1N1) 2009 influenza virus influenced the perception of pandemic vaccines, as previous pandemic preparedness had anticipated a more virulent virus. This vaccination experience provides an important opportunity for research on the long-term immunogenicity and safety of pandemic vaccines in pregnant women and children, as well as on the long-term safety of adjuvants. Preparedness for future pandemics could involve improved decision-making on target groups and increased communication on vaccine safety.
Copyright © 2010. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21075164     DOI: 10.1016/j.vaccine.2010.10.079

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Willingness to Receive the Influenza A(H1N1) Vaccine and its Determinants among University Students during the 2009 Outbreak in Turkey.

Authors:  Nazim Ercument Beyhun; Zahide Kosan; Aysun Aras; Asuman Guraksin; Talat Ezmeci
Journal:  Eurasian J Med       Date:  2014-02

2.  Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients.

Authors:  Jungmin Son; Soo Bong Lee; Dong Won Lee; Il Young Kim; Su Jin Lee; Sun Min Lee; Sang Heon Song; Eun Young Seong; Ihm Soo Kwak
Journal:  Clin Exp Nephrol       Date:  2012-09-19       Impact factor: 2.801

3.  Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain.

Authors:  Cormac J Sammon; Anita McGrogan; Julia Snowball; Corinne S de Vries
Journal:  Hum Vaccin Immunother       Date:  2013-01-30       Impact factor: 3.452

4.  Internet activity as a proxy for vaccination compliance.

Authors:  Yuval Barak-Corren; Ben Y Reis
Journal:  Vaccine       Date:  2015-04-11       Impact factor: 3.641

5.  Coordination and resource-related difficulties encountered by Quebec's public health specialists and infectious diseases/medical microbiologists in the management of A (H1N1)--a mixed-method, exploratory survey.

Authors:  Charles Nhan; Réjean Laprise; Monique Douville-Fradet; Mary Ellen Macdonald; Caroline Quach
Journal:  BMC Public Health       Date:  2012-02-10       Impact factor: 3.295

Review 6.  Review on the effects of influenza vaccination during pregnancy on preterm births.

Authors:  Marta C Nunes; Shabir A Madhi
Journal:  Hum Vaccin Immunother       Date:  2015-08-12       Impact factor: 3.452

7.  Differences in pandemic influenza vaccination policies for pregnant women in Europe.

Authors:  Johannes M Luteijn; Helen Dolk; Gordon J Marnoch
Journal:  BMC Public Health       Date:  2011-10-20       Impact factor: 3.295

Review 8.  Listen to the public and fulfil their information interests - translating vaccine communication research findings into guidance for regulators.

Authors:  Priya Bahri; Mireia Castillon Melero
Journal:  Br J Clin Pharmacol       Date:  2018-05-31       Impact factor: 4.335

9.  Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccine.

Authors:  Richard Puleston; George Bugg; Katja Hoschler; Justin Konje; James Thornton; Iain Stephenson; Puja Myles; Joanne Enstone; Glenda Augustine; Yvette Davis; Maria Zambon; Karl Nicholson; Jonathan Nguyen-Van-Tam
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study.

Authors:  F Rubinstein; P Micone; A Bonotti; V Wainer; A Schwarcz; F Augustovski; A Pichon Riviere; A Karolinski
Journal:  BMJ       Date:  2013-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.